Milan Paleja to Head Novartis India's Pharmaceuticals Business
Novartis India has appointed Mr. Milan Paleja as its new President. He will succeed Mr. Jawed Zia, who left the drug maker in March for rival Abbott India. Mr. Paleja, previously President and head of pharmaceuticals for Novartis Indonesia, will also head Novartis India’s pharmaceutical business, according to a company release. “While in Indonesia, he pioneered innovative access models, turned around the business and laid the foundation for future growth,” stated the release. He is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India.
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
24th Pharma Asia International Exhibition & Conferences to Open in Karachi, Pakistan
-
India Launches Concentrated Anti-Dumping Actions Against Eight Categories of Chinese Chemicals, Covering APIs/Intermediates, Polyurethanes, and Refrigerants
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
CPHI & PMEC India 2026
-
8th Annual Pharma Manufacturing and Automation Convention 2026
-
Pharma Manufacturing & Automation Excellence Awards 2026
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Three Major Indian Chemical Investments Target China's PC Exports
-
Pharmaconex
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
Recommend Reading
-
Is Evonik’s Massive Global Expansion of Hydroxyl-Terminated Polybutadiene (HTPB) a Technological Ambition — or a Geopolitical Gamble?
-
As Middle East Supply Faces Disruptions, SABIC's 1.8 Million Mt/Year Methanol New Project Secures Saudi Feedstock Quota
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Fracturing the Crown: BASF Antwerp’s 600-Job Cut and the Global Alarm
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
Polyethylene Weakens with Fluctuations, Trading Remains Light Before the Chinese New Year
-
Coking Coal Market Prices Remain Stable, with Little Price Fluctuation
-
The Game Between Costs and Demand: Melamine Remains Stable
-
Uses and Benefits of Sodium Selenite
-
Sodium Benzoate (E211): Safety, Benzene Risk, and Preservative Uses
- Hot Searches
- ss-31 peptide buy online
- cyanimide
- is miconazole nitrate the same as miconazole
- stanozolol sale
- hong kong chemical reagent suppliers
- ammonia water
- sodium lauryl sulfate suppliers
- reta peptide buy
- na 931 peptide for sale
- sodium potassium mag sulfates 17.5 gram-3.13 gram-1.6 gram oral solution
- mekoong
- buy 2cb online